The market for advanced biomaterials developed specifically for 3D bioprinting is growing as regenHU, an innovative bio-printing solution provider, has combined its expertise with PeptiGelDesign Technologies to provide a range of synthetic ready-to-use bioink products specifically designed for bioprinting in 3D cell biology and tissue engineering applications.
Even more so than in traditional 3D printing, material are key to the advancement of bioprinting capabilities. Bioinks are fluid-like materials which encapsulate bio-actives (living cells, proteins) which can be 3D printed into bio-architectures (e.g. custom-designed implants or tissue constructs) for drug testing. While numerous bio-inks are already obtainable, no viable solution for in-vivo relevant models were currently available.
Consequently we are very proud to announce that we can now offer an innovative series of ready-to-print synthetic hydrogels. Based on the understanding of the self-assembling behaviour of small peptides in water, the EMC-Bioink hydrogels are non-Newtonian materials which display shear thinning properties while providing a 3-dimensional peptide nanofiber scaffold that promotes both cell growth and migration.
Allowing a tight control of the mechanical strength, as well as cell-scaffold interaction, the EMC-Bioink™ family will enable researchers to produce structures that closely resemble the complex architecture and function of real tissue. Used as either a stand-alone matrix or embedded in a component system, these synthetic extracellular matrices can be used in a wide range of situations: to study tissue or disease, drug discovery, efficacy and toxicity or in the creation of regenerative implants.
regenHU is an innovative biomedical company based in Switzerland. regenHU acts as a bio-systems architect, developing new bio-manufacturing solutions in response to the emerging challenges facing the biomedical industry and regenHU’s confirmed cutting-edge solutions are currently being implemented globally. regenHU benefits from exclusive patented technologies resulting from many years of research and development in collaboration with international universities and industrial partners.
PeptiGelDesign Technologies’ (PGDt) vision is to be at the core of regenerative medicine solutions. Experts in synthetic biomaterials, the PGDt team has engineered scalable life-changing solutions in answer to presently unmet needs in the fields of Life Science and Biomedical applications. The company, based in Cheshire, UK, have developed a family of customisable self-assembling peptide-based synthetic extra cellular matrices systems that perfectly mimic the cell microenvironment. Being both reproducible and animal free products, these systems are entirely compatible with liquid handling processes and biological system interrogation techniques. PT provides user and cell friendly synthetic ECMs for 3D cell culturing as well as for Bio-printing.